• Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus

      Carrillo-Larco, Rodrigo M.; Luza-Dueñas, Anais Casandra; Urdániga-Hung, Mónica; Bernabe-Ortiz, Antonio; antonio.bernabe@upch.pe (Blackwell Publishing Ltd, 2018-11)
      Aims: To assess the diagnostic accuracy of four undiagnosed Type 2 diabetes mellitus risk scores accounting for erectile dysfunction status. Methods: This was a population-based cross-sectional study. Type 2 diabetes was defined according to a oral glucose tolerance test and self-reported physician diagnosis. Erectile dysfunction was defined according to the answer to the question, ‘Have you had difficulties obtaining an erection in the last 6 months?’ (yes/no). The risk scores used were the FINDRISC, LA-FINDRISC, American Diabetes Association score and the Peruvian Risk Score. A Poisson regression model was fitted to assess the association between Type 2 diabetes and erectile dysfunction. The area under the receiver-operating characteristic curve was estimated overall and by erectile dysfunction status. Results: A total of 799 men with a mean (sd) age of 48.6 (10.7) years were included in the study. The overall prevalence of Type 2 diabetes was 9.3%. Compared with healthy men, men with Type 2 diabetes had 2.71 (95% CI 1.57–4.66) higher chances of having erectile dysfunction. Having excluded men aware of Type 2 diabetes status (N=38), the area under the receiver-operating characteristic curve of three of the risk scores (not the American Diabetes Association score) improved among those who had erectile dysfunction in comparison with those who did not; for example, the area under the receiver-operating characteristic curve of the LA-FINDRISC score was 89.6 (95% CI 78.7–99.9) in men with erectile dysfunction and 76.5 (95% CI 68.5–84.4) overall. Conclusions: In a population-based study, erectile dysfunction was more common in men with Type 2 diabetes than in the otherwise healthy men. Screening for erectile dysfunction before screening for Type 2 diabetes seems to improve the accuracy of well-known risk scores for undiagnosed Type 2 diabetes.
      Acceso abierto
    • Neurinoma del acústico bilateral como diagnóstico de neurofibromatosis tipo 2: reporte de caso clínico

      Urdániga-Hung, Mónica; Luza-Dueñas, Anais Casandra; Chipana-Sotomayor, Marco Enrique; anais.cld.102@gmail.com (Ediciones Doyma, S.L., 2017-06)
      Neurofibromatosis type 2 (NF2) is an autosomal dominant genetic disease that is characterized by the presence of bilateral schwannomas, meningiomas and gliomas. This is a case report of a woman of 34 years who has bilateral hipoacusia, left facial paralysis and consciousness loss in who it has been realized magnetic resonance imaging (MRI) and it has been found two mases scavenging contrast in the angle pontocerebellar. It has been established NF2 as presumptive diagnostic by diagnostic criteria. The bigger lesion was resected surgically and it has been obtained histopathologic specimens that showed acoustic schwannomas.Conclusion: The findings of MRI can be used as diagnostic method.